达瑞生物 (832705.OC)

+ 收藏

资产负债表(达瑞生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
流动资产:
 货币资金(元) 163,958,320.39159,433,307.69195,541,549.53276,606,516.46193,329,080.92
  其中:交易性金融资产(元) 50,000,000.0040,040,833.3351,000,000.00-90,000,000.00
 应收票据及应收账款(元) 124,043,347.90114,451,036.24183,715,474.39213,625,243.04131,975,043.34
  其中:应收票据(元) ----650,000.00
  其中:应收账款(元) 124,043,347.90114,451,036.24183,715,474.39213,625,243.04131,325,043.34
 预付款项(元) 6,476,064.829,614,601.769,597,120.9511,222,170.5123,985,300.01
 其他应收款(元) 2,158,621.092,026,462.572,547,107.282,469,854.403,279,660.27
 存货(元) 46,579,751.2234,285,439.2847,058,007.0152,919,704.8552,940,073.31
 其他流动资产(元) 1,001,511.901,250,601.371,528,767.511,863,331.242,285,517.97
 流动资产合计(元) 394,217,617.32361,102,282.24490,988,026.67558,706,820.50497,794,675.82
非流动资产:
 长期股权投资(元) 2,142,442.922,032,832.805,561,295.719,963,647.0710,323,834.39
 其他非流动金融资产(元) 30,394,177.1430,889,420.0036,766,992.2737,549,386.6840,055,600.81
 固定资产(元) 86,103,619.8890,997,778.7696,664,932.9097,448,227.4199,154,714.89
 在建工程(元) 351,490.75163,920.00117,920.002,910,245.60199,000.00
 使用权资产(元) 5,000,081.595,810,553.017,161,311.318,650,964.175,670,315.36
 无形资产(元) 77,662,797.4984,514,345.3298,506,923.2882,851,396.8062,041,466.43
 开发支出(元) 33,343,085.5629,577,924.6446,370,669.2462,846,513.8090,513,825.61
 长期待摊费用(元) 5,556,050.136,441,856.877,489,699.483,620,016.985,238,967.86
 递延所得税资产(元) 6,756,744.136,492,970.1229,835,352.5824,230,595.1417,390,201.71
 其他非流动资产(元) 109,964,395.84108,251,826.39-123,115.00-
 非流动资产合计(元) 357,274,885.43365,173,427.91328,475,096.77330,194,108.65330,587,927.06
资产总计(元) 751,492,502.75726,275,710.15819,463,123.44888,900,929.15828,382,602.88
流动负债:
 应付票据及应付账款(元) 44,848,446.7634,327,784.5232,333,329.8861,059,996.5745,690,951.70
  其中:应付账款(元) 44,848,446.7634,327,784.5232,333,329.8861,059,996.5745,690,951.70
 合同负债(元) 7,084,760.036,243,029.446,811,962.556,623,308.054,796,816.07
 应付职工薪酬(元) 7,495,705.3315,861,483.6915,195,603.4132,307,111.5117,054,396.87
 应交税费(元) 1,249,737.09670,379.061,886,078.1310,309,483.666,608,201.82
 其他应付款(元) 44,208,283.7746,773,583.1659,246,564.6161,390,821.6248,192,906.18
 一年内到期的非流动负债(元) 1,625,856.051,510,208.612,033,274.992,592,945.591,922,944.19
 其他流动负债(元) 410,063.72316,022.33405,182.80347,602.11373,242.71
 流动负债合计(元) 106,922,852.75105,702,490.81117,911,996.37174,631,269.11124,639,459.54
非流动负债:
 租赁负债(元) 3,898,274.944,735,389.005,524,130.996,245,597.613,872,969.56
 递延收益(元) 25,840,311.274,202,378.855,216,154.152,011,885.361,326,748.91
 递延所得税负债(元) 596,800.87646,084.26---
 非流动负债合计(元) 30,335,387.089,583,852.1110,740,285.148,257,482.975,199,718.47
负债合计(元) 137,258,239.83115,286,342.92128,652,281.51182,888,752.08129,839,178.01
所有者权益(或股东权益):
 实收资本或股本(元) 279,399,974.00279,399,974.00279,399,974.00279,399,974.00279,399,974.00
 资本公积(元) 336,007,658.08336,007,658.08346,428,710.05346,428,710.05343,653,080.37
 其他综合收益(元) 318,417.80250,189.55422,161.90111,577.54-304,172.20
 盈余公积(元) 15,667,605.0215,667,605.0215,667,605.0215,667,605.0215,667,605.02
 未分配利润(元) -16,105,513.17-19,322,812.1849,728,860.6165,174,639.7060,714,767.15
 归属于母公司股东权益合计(元) 615,288,141.73612,002,614.47691,647,311.58706,782,506.31699,131,254.34
 少数股东权益(元) -1,053,878.81-1,013,247.24-836,469.65-770,329.24-587,829.47
 股东权益合计(元) 614,234,262.92610,989,367.23690,810,841.93706,012,177.07698,543,424.87
负债和股东权益合计(元) 751,492,502.75726,275,710.15819,463,123.44888,900,929.15828,382,602.88
公告日期 2024-08-302024-03-292023-08-302023-03-302022-08-29
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院